Literature DB >> 11703317

Practical management of iron overload.

J B Porter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11703317     DOI： 10.1046/j.1365-2141.2001.03195.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  68 in total

Review 1.  Optimizing therapy for iron overload in the myelodysplastic syndromes: recent developments.

Authors:  Heather A Leitch
Journal:  Drugs       Date:  2011-01-22       Impact factor: 9.546

Review 2.  Clinical research: a tale of two studies.

Authors:  David G Nathan
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

3.  Role of CMR feature-tracking derived left ventricular strain in predicting myocardial iron overload and assessing myocardial contractile dysfunction in patients with thalassemia major.

Authors:  Vineeta Ojha; Kartik P Ganga; Tulika Seth; Ambuj Roy; Nitish Naik; Priya Jagia; Gurpreet S Gulati; Sanjeev Kumar; Sanjiv Sharma
Journal:  Eur Radiol       Date:  2021-03-15       Impact factor: 5.315

Review 4.  Deferasirox: oral, once daily iron chelator--an expert opinion.

Authors:  M B Agarwal
Journal:  Indian J Pediatr       Date:  2010-02-23       Impact factor: 1.967

5.  Evaluation of myocardial iron overload by T2* cardiovascular magnetic resonance imaging.

Authors:  Benjamin Cheong; Steffen Huber; Raja Muthupillai; Scott D Flamm
Journal:  Tex Heart Inst J       Date:  2005

6.  HFE gene mutations, serum ferritin level, transferrin saturation, and their clinical correlates in a Korean population.

Authors:  Sang Hyub Lee; Jin-Wook Kim; So Hyun Shin; Kyoung Phil Kang; Hyun Cheol Choi; Sung Hee Choi; Kyoung Un Park; Hyun Young Kim; Weechang Kang; Sook-Hyang Jeong
Journal:  Dig Dis Sci       Date:  2008-08-06       Impact factor: 3.199

Review 7.  Quantification of liver iron with MRI: state of the art and remaining challenges.

Authors:  Diego Hernando; Yakir S Levin; Claude B Sirlin; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

8.  Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.

Authors:  Emilio Paolo Alessandrino; Matteo Giovanni Della Porta; Andrea Bacigalupo; Luca Malcovati; Emanuele Angelucci; Maria Teresa Van Lint; Michele Falda; Francesco Onida; Massimo Bernardi; Stefano Guidi; Barbarella Lucarelli; Alessandro Rambaldi; Raffaella Cerretti; Paola Marenco; Pietro Pioltelli; Cristiana Pascutto; Rosi Oneto; Laura Pirolini; Renato Fanin; Alberto Bosi
Journal:  Haematologica       Date:  2009-11-10       Impact factor: 9.941

9.  Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias.

Authors:  Maria Domenica Cappellini; John Porter; Amal El-Beshlawy; Chi-Kong Li; John F Seymour; Mohsen Elalfy; Norbert Gattermann; Stéphane Giraudier; Jong-Wook Lee; Lee Lee Chan; Kai-Hsin Lin; Christian Rose; Ali Taher; Swee Lay Thein; Vip Viprakasit; Dany Habr; Gabor Domokos; Bernard Roubert; Antonis Kattamis
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

10.  Enzymatically Biodegradable Polyrotaxane-Deferoxamine Conjugates for Iron Chelation.

Authors:  Zhi Liu; Tien-Min Lin; Max Purro; May P Xiong
Journal:  ACS Appl Mater Interfaces       Date:  2016-09-26       Impact factor: 9.229
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.